Ferrlecit 12.5 mg/mL
sodium ferric gluconate complex · INJECTION · sanofi-aventis U.S. LLC
No Recall HistoryCurrently in Shortage
Plain English
Ferrlecit is a injection containing sodium ferric gluconate complex at 12.5 mg/mL, taken intravenous. Manufactured by sanofi-aventis U.S. LLC.
Key Facts
- Brand Name
- Ferrlecit
- Generic Name
- sodium ferric gluconate complex
- NDC Code (Product)
0024-2794- Manufacturer
- sanofi-aventis U.S. LLC
- Strength
- 12.5 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA020955
- Drug Class
- Parenteral Iron Replacement [EPC]
- Marketing Start
- 07/07/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is Ferrlecit used for?
Ferrlecit contains sodium ferric gluconate complex. It is a injection taken intravenous. Consult your doctor for specific uses.
Is Ferrlecit a controlled substance?
Ferrlecit is not classified as a controlled substance by the DEA.
What is the generic name for Ferrlecit?
The generic name for Ferrlecit is sodium ferric gluconate complex. There are 2 other brand versions of sodium ferric gluconate complex.
What is the NDC code for Ferrlecit 12.5 mg/mL?
The NDC (National Drug Code) for Ferrlecit 12.5 mg/mL is 0024-2794, listed by sanofi-aventis U.S. LLC.